CanSino Biologics, Inc. (CASBF)
3.86
0.00 (0.00%)
USD |
OTCM |
May 08, 16:00
Price Chart
Key Stats
| Price and Performance | |
|---|---|
| Market Cap | 953.59M |
| 52 Week High (Daily) | |
| 52 Week Low (Daily) | |
| All-Time High (Daily) | |
| Year to Date Total Returns (Daily) | |
| 1 Month Total Returns (Daily) | |
| 1 Year Total Returns (Daily) | 20.62% |
| Valuation | |
| PE Ratio | -- |
| PE Ratio (Forward) | |
| PS Ratio | 6.051 |
| Price to Book Value | 1.337 |
| EV to EBITDA | |
| Dividend | |
|---|---|
| Dividend | -- |
| Dividend Yield (Forward) | |
| Financials | |
| Revenue (5 Year Growth) | |
| Revenue (Quarterly YoY Growth) | |
| EPS Diluted (5 Year Growth) | |
| EPS Diluted (Quarterly YoY Growth) | |
| Debt to Equity Ratio | 0.2358 |
| Return on Equity | |
| Return on Assets | |
| Risk | |
| Beta (5Y) | |
| Max Drawdown (5Y) | 96.53% |
Profile
| CanSino Biologics, Inc. engages in the research and development, manufacturing, and sale of vaccines. It offers shingles, meningitis, polio, adenovirus, and tuberculosis vaccines. The company was founded by Xuan Liu, Xue Feng Yu, Tao Zhu, Dong Xu Qiu and Hui Hua Mao on January 13, 2009 and is headquartered in Tianjin, China. |
| URL | http://www.cansinotech.com |
| Investor Relations URL | N/A |
| HQ State/Province | Tianjin |
| Sector | Health Care |
| Industry | Biotechnology |
| Next Earnings Release | Aug. 20, 2026 (est.) |
| Last Earnings Release | Apr. 28, 2026 |
| Next Ex-Dividend Date | N/A |
| Last Ex-Dividend Date | Jul. 14, 2022 |
Profile
| CanSino Biologics, Inc. engages in the research and development, manufacturing, and sale of vaccines. It offers shingles, meningitis, polio, adenovirus, and tuberculosis vaccines. The company was founded by Xuan Liu, Xue Feng Yu, Tao Zhu, Dong Xu Qiu and Hui Hua Mao on January 13, 2009 and is headquartered in Tianjin, China. |
| URL | http://www.cansinotech.com |
| Investor Relations URL | N/A |
| HQ State/Province | Tianjin |
| Sector | Health Care |
| Industry | Biotechnology |
| Next Earnings Release | Aug. 20, 2026 (est.) |
| Last Earnings Release | Apr. 28, 2026 |
| Next Ex-Dividend Date | N/A |
| Last Ex-Dividend Date | Jul. 14, 2022 |